Blend Labs (NYSE:BLND – Free Report) had its price objective decreased by Wells Fargo & Company from $4.00 to $3.00 in a research note issued to investors on Friday morning,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock.
Several other equities research analysts have also weighed in on the company. Zacks Research lowered Blend Labs from a “hold” rating to a “strong sell” rating in a report on Monday, July 13th. The Goldman Sachs Group set a $3.50 price objective on shares of Blend Labs in a report on Friday, May 8th. Citizens Jmp reiterated a “market outperform” rating and set a $4.00 target price on shares of Blend Labs in a research report on Tuesday, July 21st. Canaccord Genuity Group reduced their target price on shares of Blend Labs from $5.25 to $4.50 and set a “buy” rating for the company in a research note on Friday, May 15th. Finally, Citigroup reissued a “market outperform” rating on shares of Blend Labs in a research report on Tuesday, July 21st. Four analysts have rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, Blend Labs presently has a consensus rating of “Hold” and an average price target of $3.07.
Check Out Our Latest Analysis on BLND
Blend Labs Price Performance
Institutional Trading of Blend Labs
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. PFG Advisors boosted its position in shares of Blend Labs by 4.9% in the fourth quarter. PFG Advisors now owns 78,956 shares of the company’s stock valued at $240,000 after acquiring an additional 3,684 shares during the period. Moneta Group Investment Advisors LLC grew its stake in Blend Labs by 18.4% during the third quarter. Moneta Group Investment Advisors LLC now owns 33,922 shares of the company’s stock valued at $124,000 after acquiring an additional 5,265 shares in the last quarter. Covestor Ltd grew its stake in Blend Labs by 40.1% during the fourth quarter. Covestor Ltd now owns 18,909 shares of the company’s stock valued at $57,000 after acquiring an additional 5,409 shares in the last quarter. Barclays PLC increased its holdings in Blend Labs by 1.5% during the 4th quarter. Barclays PLC now owns 397,203 shares of the company’s stock worth $1,207,000 after acquiring an additional 6,001 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its holdings in Blend Labs by 6.4% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 121,961 shares of the company’s stock worth $371,000 after acquiring an additional 7,368 shares during the period. 52.56% of the stock is currently owned by institutional investors.
Blend Labs News Summary
Here are the key news stories impacting Blend Labs this week:
- Positive Sentiment: Blend reported second-quarter revenue of $33.84 million, exceeding the $33.08 million analyst consensus. Wells Fargo also maintained an “overweight” rating, indicating it still sees potential for significant upside despite reducing its price target to $3.00. Blend Announces Second Quarter 2026 Financial Results Wells Fargo price target update
- Neutral Sentiment: Management discussed the second-quarter results and business outlook during the earnings call, giving investors additional context on operating performance and future growth prospects. Blend Labs Q2 2026 Earnings Call Transcript
- Negative Sentiment: Second-quarter earnings were weaker than expected. Reports variously characterized results as break-even or a $0.02-per-share loss, versus consensus expectations for $0.02 per share in earnings. The earnings shortfall likely increased selling pressure even though revenue exceeded estimates. Blend Labs Reports Break-Even Earnings for Q2
- Negative Sentiment: Blend guided for third-quarter revenue of $31.5 million to $33.5 million, below the $34.2 million consensus estimate. The outlook implies a potential sequential slowdown and is the clearest negative catalyst in the latest update. Blend Labs Earnings Results
- Negative Sentiment: Wells Fargo lowered its price target from $4.00 to $3.00. Although the analyst remains bullish, the cut reflects more cautious expectations for Blend’s near-term performance. Wells Fargo price target update
About Blend Labs
Blend Labs, Inc operates as a financial technology company that offers a digital consumer banking platform designed to simplify and automate the lending and account opening processes for banks and credit unions. Its cloud-native software enables financial institutions to deliver a more seamless customer experience by consolidating multiple steps—such as application intake, identity verification, document collection and underwriting—into a unified digital workflow. Blend’s platform is built to integrate with existing core banking systems and third-party data providers, allowing clients to accelerate loan origination and deposit account opening while maintaining compliance and security standards.
The company’s product suite includes solutions for mortgage origination, home equity lending, consumer personal lending and deposit account opening.
Recommended Stories
- Five stocks we like better than Blend Labs
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Blend Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blend Labs and related companies with MarketBeat.com's FREE daily email newsletter.
